Baird Medical Investment (NASDAQ:BDMD) and Beta Bionics (NASDAQ:BBNX) Financial Contrast

Baird Medical Investment (NASDAQ:BDMD) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation and analyst recommendations.

Volatility and Risk

Baird Medical Investment has a beta of -1.41, indicating that its share price is 241% less volatile than the S&P 500. Comparatively, Beta Bionics has a beta of 5.6, indicating that its share price is 460% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations for Baird Medical Investment and Beta Bionics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1	0	0	0	1.00
Beta Bionics	1	3	6	1	2.64

Beta Bionics has a consensus price target of $23.20, indicating a potential upside of 123.29%. Given Beta Bionics’ stronger consensus rating and higher probable upside, analysts plainly believe Beta Bionics is more favorable than Baird Medical Investment.

Institutional & Insider Ownership

19.8% of Baird Medical Investment shares are held by institutional investors. 78.9% of Baird Medical Investment shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Baird Medical Investment and Beta Bionics”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	N/A	N/A	N/A	N/A	N/A
Beta Bionics	$100.25 million	4.60	-$73.20 million	($1.95)	-5.33

Baird Medical Investment has higher earnings, but lower revenue than Beta Bionics.

Profitability

This table compares Baird Medical Investment and Beta Bionics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Beta Bionics	-73.02%	-20.29%	-18.32%

Summary

Beta Bionics beats Baird Medical Investment on 6 of the 11 factors compared between the two stocks.

About Baird Medical Investment

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

About Beta Bionics

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.